Gainers
- Hempacco Co., Inc. (NASDAQ:HPCO) shares jumped 63.4% to close at $8.35 after dropping 34% on Wednesday. Hempacco's common shares began trading on the Nasdaq Tuesday. The company had planned to offer 1 million shares of common stock at a public offering price of $6 per share for total gross proceeds of $6 million.
- GigaCloud Technology Inc. (NASDAQ:GCT) climbed 61.4% to close at $23.65.
- Virax Biolabs Group Limited (NASDAQ:VRAX) surged 58.7% to settle at $5.57.
- Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) jumped 51% to close at $20.24 after Novo Nordisk announced it will acquire the company for $20 per share in cash.
- ShiftPixy, Inc. (NASDAQ:PIXY) surged 46.9% to close at $20.58 on Thursday. ShiftPixy announced a 1-for-100 reverse stock split.
- Shuttle Pharmaceuticals, Inc. (NASDAQ:SHPH) shares surged 36.2% to close at $52.40 amid post-IPO volatility. The company priced its IPO at $8.125 per unit.
- Kuke Music Holding Limited (NYSE:KUKE) jumped 32.9% to close at $1.13.
- Nutanix, Inc. (NASDAQ:NTNX) gained 29.1% to close at $22.34 after the company reported better-than-expected sales results for its fourth quarter and issued strong revenue forecast.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) climbed 28.6% to close at $0.3060. InMed Pharmaceuticals recently announced a 1:25 share consolidation to meet Nasdaq listing criteria.
- Eyenovia, Inc. (NASDAQ:EYEN) gained 25.2% to settle at $2.04.
- Twin Disc, Incorporated (NASDAQ:TWIN) jumped 24.6% to close at $11.59 after the company posted a profit for the fourth quarter.
- Immuneering Corporation (NASDAQ:IMRX) rose 24.6% to settle at $6.95.
- Immuneering, last month, posted a Q2 loss of $0.44 per share.
- Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) gained 23.2% to close at $2.18 after the company announced it has entered into a purchase agreement with Arena Business Solutions for up to $15 million of the company's common stock.
- Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) jumped 22.4% to close at $4.75.
- Alaunos Therapeutics, Inc. (NASDAQ:TCRT) rose 22.4% to close at $3.01.
- Purple Innovation, Inc. (NASDAQ:PRPL) jumped 20.3% to settle at $3.44 after the company announced the acquisition of Intellibed.
- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) gained 20% to close at $30.59. Agios Pharmaceuticals, last month, reported better-than-expected Q2 EPS and sales results.
- Werewolf Therapeutics, Inc. (NASDAQ:HOWL) jumped 19.6% to settle at $6.05. Werewolf Therapeutics initiated patient dosing in a Phase 1/1b clinical trial evaluating WTX-124, its lead INDUKINET molecule targeting IL-2 for the treatment of solid tumors.
- RiceBran Technologies (NASDAQ:RIBT) gained 18.6% to close at $2.74. The company, last month, posted upbeat quarterly sales.
- PaxMedica, Inc. (NASDAQ:PXMD) climbed 18.2% to close at $3.50. PaxMedica Executive Chairman, Director Michael Derby reported in Form4 filing purchase of 95,000 shares at $5.25 per share.
- Belite Bio, Inc (NASDAQ:BLTE) jumped 14.3% to close at $36.70. Belite Bio recently announced it has commenced enrollment for the US Phase 3 clinical trial of LBS-008 in patients with Stargardt Disease.
- Turquoise Hill Resources Ltd. (NYSE:TRQ) rose 13.9% to close at $31.30. Rio Tinto Group announced plans to acquire full ownership of Turquoise Hill Resources for C$43 per share in cash.
- Bright Green Corporation (NASDAQ:BGXX) shares rose 12.3% to close at $1.55 after gaining around 33% on Wednesday.
- Bausch Health Companies Inc. (NYSE:BHC) gained 10.4% to close at $6.59. RBC Capital maintained Bausch Health Companies with a Sector Perform and raised the price target from $4.5 to $8.
- Relay Therapeutics, Inc. (NASDAQ:RLAY) climbed 8.4% to settle at $24.90. Stifel initiated coverage on Relay Therapeutics with a Buy rating and announced a price target of $40 today.
- DXC Technology Company (NYSE:DXC) gained 7.8% to settle at $26.70.
- Snap Inc. (NYSE:SNAP) jumped 7% to close at $11.64 after multiple analysts raised their price targets on the stock. The company on Wednesday announced restructuring plans and a workforce reduction.
- Five Below, Inc. (NASDAQ:FIVE) rose 6.3% to close at $135.92 after the company reported Q2 earnings results.
